WVU Medicine is playing a lead role in a national clinical study of a minimally invasive surgical procedure for people who've ...

Obesity is an epidemic in the United States, but more people are shedding pounds with the help of weight loss drugs.

Eli Lilly continues to see strong growth coming from its GLP-1 drugs. The company's current 2025 guidance looks conservative.

Clinic Secret prescribes GLP-1 medications, including semaglutide and tirzepatide. These medications are FDA-approved and can be effective for weight loss and blood sugar control. Are the ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

More and more Americans are turning to GLP-1 injections to lose weight. FOX 7 Austin's Rebecca Thomas spoke to an Austin ...

A human-derived, ultra-long-acting GLP-1 injection independently researched and developed by Innogen, a Shanghai-based ...

After just a few years on the market, a new wave of GLP-1 drugs approved for weight loss have upended what we know about obesity. By now, these are household names: Mounjaro. Wegovy. Zepbound ...

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in ...

Since the approval ... vision loss, they should call their internist about possibly adjusting the dosage or stopping the medication. “We have other ways to control diabetes and weight loss ...